Search research articles
Contact Us
Filters
Showing results (191-200 of 247) with videos related to
Page
of 25
Sort By:
Iscience
|
August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
Cansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Gastrointestinal germinal center B cell depletion and reduction in IgA <sup>+</sup> plasma cells in HIV-1 infection
Francesca Cossarini, Joan Shang, Azra Krek, et al.
Blood
|
March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Livius Penter, Yi Zhang, Alexandra Savell, et al.
Blood
|
January 27, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Livius Penter, Yang Liu, Jacquelyn O Wolff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2021
Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Arta M Monjazeb, Anita Giobbie-Hurder, Ana Lako, et al.
Nature Medicine
|
January 19, 2024
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Science (New York, N.Y.)
|
September 5, 2024
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis
Matthew D Park, Jessica Le Berichel, Pauline Hamon, et al.
Cancer Research Communications
|
March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
Lijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Nature
|
December 6, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Nelson M LaMarche, Samarth Hegde, Matthew D Park, et al.
Nature Medicine
|
October 2, 2023
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 247) with videos related to
Sort By:
Page
of 25
Iscience
|
August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
Cansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Gastrointestinal germinal center B cell depletion and reduction in IgA <sup>+</sup> plasma cells in HIV-1 infection
Francesca Cossarini, Joan Shang, Azra Krek, et al.
Blood
|
March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Livius Penter, Yi Zhang, Alexandra Savell, et al.
Blood
|
January 27, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Livius Penter, Yang Liu, Jacquelyn O Wolff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2021
Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Arta M Monjazeb, Anita Giobbie-Hurder, Ana Lako, et al.
Nature Medicine
|
January 19, 2024
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Science (New York, N.Y.)
|
September 5, 2024
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis
Matthew D Park, Jessica Le Berichel, Pauline Hamon, et al.
Cancer Research Communications
|
March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
Lijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Nature
|
December 6, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Nelson M LaMarche, Samarth Hegde, Matthew D Park, et al.
Nature Medicine
|
October 2, 2023
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Page
of 25